Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
40
LOBE.CX Quote, Financials, Valuation and Earnings
Last price:
$0.04
Seasonality move
:
27%
Day range:
$0.04 - $0.04
52-week range:
$0.02 - $0.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
38.3K
1-year change:
75%
Market cap:
$6.8M
Revenue:
$136.2K
EPS (TTM):
-$0.03
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Lobe Sciences Ltd. has 20317.62% upside to fair value with a price target of -- per share.
LOBE.CX vs. S&P 500
-
Over the past 5 trading days, Lobe Sciences Ltd. has underperformed the S&P 500 by -11.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lobe Sciences Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lobe Sciences Ltd. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Lobe Sciences Ltd. reported revenues of --.
Earnings Growth
-
Lobe Sciences Ltd. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Lobe Sciences Ltd. reported earnings per share of -$0.01.
Enterprise value:
9.4M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.13x
EV / Free cash flow:
-9.12x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-264.47%
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
-1117.27%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-05-31 | 2024-05-31 | 2025-05-31 | 2024-05-31 | 2025-05-31 | |
| Income Statement | ||||||
| Revenue | -- | $976.7K | -- | -- | -- | |
| Gross Profit | -$29.3K | $841.7K | -- | -$28.2K | -- | |
| Operating Income | -$5.3M | -$1.8M | -$2.7M | -$590.4K | -$1.1M | |
| EBITDA | -$5.3M | -$1.7M | -$2.7M | -$562.1K | -$1.1M | |
| Diluted EPS | -$0.11 | -$0.03 | -$0.03 | -$0.00 | -$0.01 | |
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.6M | $2.4M | $889.6K | $65.4K | $8M | |
| Total Assets | $28.8M | $3.3M | $3.7M | $2M | $8M | |
| Current Liabilities | $547K | $1.1M | $2.5M | $1.1M | $2.8M | |
| Total Liabilities | $1.2M | $1.1M | $2.5M | $3.1M | $4.6M | |
| Total Equity | $27.6M | $2.3M | $1.2M | -$1.1M | $3.4M | |
| Total Debt | -- | -- | -- | $1.9M | $1.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-05-31 | 2024-05-31 | 2025-05-31 | 2024-05-31 | 2025-05-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.7M | -$1.1M | -$1M | -$322K | -$408.2K | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | $1.6M | $349K | $9M | $337.8K | $8.3M | |
| Free Cash Flow | -$1.7M | -$1.1M | -$1M | -$322K | -$408.2K | |
LOBE.CX
Sector
Market Cap
$6.8M
--
Price % of 52-Week High
43.75%
--
Dividend Yield
0%
--
Shareholder Yield
-13.86%
--
1-Year Price Total Return
75%
--
Beta (5-Year)
0.215
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.04
200-day SMA
Buy
Level
$0.04
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$0.04
Relative Strength Index (RSI14)
Sell
Level
38.27
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-66.6667
50-day SMA
Sell
Level
$0.04
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-252.297)
Sell
CA Score
(Annual)
Level (-16.055)
Buy
Beneish M-Score
(Annual)
Level (-78.87)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (101.9972)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lobe Sciences Ltd. is a biopharmaceutical company, which engages in the discovery and development of transformative medicines to treat rare diseases. It involves in drug research and development using non-hallucinatory doses of stabilized psilocin-based compounds to address unmet medical needs in orphan neurological therapeutic applications. The company was founded on May 13, 2010 and is headquartered in Vancouver, Canada.
Stock Forecast FAQ
In the current month, LOBE.CX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LOBE.CX average analyst price target in the past 3 months is --.
-
Where Will Lobe Sciences Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lobe Sciences Ltd. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Lobe Sciences Ltd.?
Analysts are divided on their view about Lobe Sciences Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lobe Sciences Ltd. is a Sell and believe this share price will drop from its current level to --.
-
What Is Lobe Sciences Ltd.'s Price Target?
The price target for Lobe Sciences Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LOBE.CX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lobe Sciences Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LOBE.CX?
You can purchase shares of Lobe Sciences Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lobe Sciences Ltd. shares.
-
What Is The Lobe Sciences Ltd. Share Price Today?
Lobe Sciences Ltd. was last trading at $0.04 per share. This represents the most recent stock quote for Lobe Sciences Ltd.. Yesterday, Lobe Sciences Ltd. closed at $0.04 per share.
-
How To Buy Lobe Sciences Ltd. Stock Online?
In order to purchase Lobe Sciences Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get LOBE.CX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LOBE.CX
Sector
P/E ratio
--
--
PEG ratio
-0.13x
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
LOBE.CX
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
-29.35%
--
Earnings forecast
--
--
Profitability
LOBE.CX
Sector
Profitability FY 2024
$49.7K
--
Return on invested capital
-1117.27%
--
Return on assets
-264.47%
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
16
Next Earnings Date
Dec
16
Estimated Next Earnings Date
Mar
17
Balance Sheet
LOBE.CX
Sector
Total cash
$8M
--
Short term investments
--
--
Total assets
$258.6K
--
Long term debt
$2.5M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
73
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 39x
Alerts
Buy
80
FEIM alert for Dec 15
Frequency Electronics, Inc. [FEIM] is down 3.51% over the past day.
Buy
57
MOD alert for Dec 15
Modine Manufacturing Co. [MOD] is up 1.79% over the past day.
Sell
42
OKLO alert for Dec 15
Oklo, Inc. [OKLO] is down 5.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
